<DOC>
	<DOCNO>NCT01763606</DOCNO>
	<brief_summary>Patients cancer develop stroke high risk future stroke clot event . These patient routinely treat medicine thin blood , include enoxaparin aspirin . However , unclear medicine best whether medicine adequately study clinical trial . The purpose Phase I/II study determine clinical trial different blood thinner patient cancer stroke possible . In addition , study aim compare effect , good and/or bad , enoxaparin aspirin patient cancer recent stroke .</brief_summary>
	<brief_title>Enoxaparin Versus Aspirin Patients With Cancer Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Any adult patient active systemic cancer diagnose acute ischemic stroke main MSKCC campus MSKCC 's New York City outpatient center WCMC , NYPH/CUMC within prior four week would eligible . 18 85 year age . Active cancer , define pathologic diagnosis treatment cancer , basalcell squamouscell carcinoma skin , within past six month ; patient know recurrent metastatic disease within past six month . A pathology report issue enrol site confirm diagnosis cancer require enrollment . Acute ischemic stroke within prior four week , define new neurologic deficit ( ) MRI evidence acute ischemia referable location , clinical radiologic indication noncerebrovascular mimic , brain metastasis , etiology deficit ( ) . Inability get brain MRI Known malignant primary brain tumor . Diagnosis intracranial hemorrhage within past 3 month , include intratumoral hemorrhage brain metastasis systemic cancer . Active serious bleed within two week enrollment . Patient condition associate high risk bleed recent surgery peptic ulcer disease . Clear indication anticoagulation ( e.g. , atrial fibrillation ) anticipate study period . Clear indication antiplatelet agent ( e.g. , cardiac stent ) ; patient receive aspirin primary prevention prior index stroke may enrol long study investigator believe would safe patient stop aspirin patient randomize enoxaparin arm . Active bleeding diathesis . Platelet count â‰¤ 70,000/mm3 , international normalize ratio ( INR ) &gt; 1.6 , partial thromboplastin time ( PTT ) &gt; 40 second . Known allergy heparin aspirin history heparin induce thrombocytopenia . Serum creatinine &gt; 2 mg/dl . AST ALT &gt; 200 U/L . Hemoglobin &lt; 8 gm/dl Symptomatic carotid stenosis . Active pregnancy . Life expectancy &lt; 1 month current hospice care Unavailability followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Enoxaparin</keyword>
	<keyword>Aspirin</keyword>
	<keyword>stroke</keyword>
	<keyword>12-264</keyword>
</DOC>